dasiglucagon

dasiglucagon
Trade Name
Orphan Indication Hypoglycemia in patients with congenital hyperinsulinism (CH)
USA Market Approval USA
USA Designation Date 2017-08-10 00:00:00
Sponsor Zealand Pharma A/S;36 Smedeland;Glostrup